These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 11113863
1. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. Davidson B, Berner A, Nesland JM, Risberg B, Berner HS, Tropè CG, Kristensen GB, Bryne M, Ann Florenes V. J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863 [Abstract] [Full Text] [Related]
2. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B, Berner A, Nesland JM, Risberg B, Kristensen GB, Tropé CG, Bryne M. Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [Abstract] [Full Text] [Related]
3. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer. Ohene-Abuakwa Y, Noda M, Perenyi M, Kobayashi N, Kashima K, Hattori T, Pignatelli M. J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859 [Abstract] [Full Text] [Related]
4. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF, Blamey RW, Ellis IO. J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116 [Abstract] [Full Text] [Related]
5. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. Papadavid E, Pignatelli M, Zakynthinos S, Krausz T, Chu AC. J Pathol; 2002 Feb; 196(2):154-62. PubMed ID: 11793366 [Abstract] [Full Text] [Related]
6. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL. J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479 [Abstract] [Full Text] [Related]
7. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications. Davidson B, Risberg B, Berner A, Nesland JM, Tropé CG, Kristensen GB, Bryne M, Goscinski M, van de Putte G, Flørenes VA. Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079 [Abstract] [Full Text] [Related]
8. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. Ramasami S, Kerr KM, Chapman AD, King G, Cockburn JS, Jeffrey RR. J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858 [Abstract] [Full Text] [Related]
10. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR, Fonsechi-Carvasan GA, De Angelo Andrade LA, Böttcher-Luiz F. Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [Abstract] [Full Text] [Related]
11. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. Bukholm IK, Nesland JM, Børresen-Dale AL. J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987 [Abstract] [Full Text] [Related]
12. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Davidson B, Baekelandt M, Shih IeM. Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338 [Abstract] [Full Text] [Related]
13. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast. Gillett CE, Miles DW, Ryder K, Skilton D, Liebman RD, Springall RJ, Barnes DM, Hanby AM. J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001 [Abstract] [Full Text] [Related]
14. [Correlation of E-cadherin, beta-catenin and gamma-catenin gene expression with the invasion and metastasis of gastric carcinoma]. Wang CX, Chen J, Yang Z, Song W, Du ZL, Li ZH. Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1198-201. PubMed ID: 14625188 [Abstract] [Full Text] [Related]
15. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, van Roy FM, Birembaut PL. J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137 [Abstract] [Full Text] [Related]
16. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. Bagutti C, Speight PM, Watt FM. J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134 [Abstract] [Full Text] [Related]
17. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Davidson B, Lazarovici P, Ezersky A, Nesland JM, Berner A, Risberg B, Tropé CG, Kristensen GB, Goscinski M, van de Putte G, Reich R. Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863 [Abstract] [Full Text] [Related]
18. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, Uchida T, Fukumoto M, Ito M. Oncol Rep; 2001 Nov; 8(2):249-55. PubMed ID: 11182035 [Abstract] [Full Text] [Related]
19. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [Abstract] [Full Text] [Related]
20. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas. Washington K, Chiappori A, Hamilton K, Shyr Y, Blanke C, Johnson D, Sawyers J, Beauchamp D. Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359 [Abstract] [Full Text] [Related] Page: [Next] [New Search]